In the trial, patients who received a once-weekly 20 mg injection of amycretin over 36 weeks saw an impressive 22% reduction ...

Ten companies, predominantly under the health, energy, and technology sectors—mirrored the gains on the back of stronger ...

Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth ...

Shares of Tempus AI Inc. (NASDAQ: TEM) surged 35% on Tuesday, bringing its market capitalization to $7.5 billion. The rally ...

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday. The stock appears to be moving on continued momentum from ...

We recently published a list of 10 Buzzing AI Stocks on Latest News and Ratings. In this article, we are going to take a look ...

Shares of Tempus AI (NASDAQ:TEM) are soaring 36% higher in midday trading after it was revealed former House Speaker Nancy Pelosi had been recently buying the stock. The California congresswoman has a ...

In addition to gains powered by Pelosi's options purchase disclosure, Tempus Ai stock is also getting a boost from the rollout of its AI-powered olivia healthcare app. The software is designed to ...

Shares of Tempus AI (TEM) were up 33% to $46.85 in afternoon trading after the company announced the national launch of olivia earlier. Olivia ...

Shares of Tempus AI (TEM) were up 32% in pre-market open trading to $46.73 after the company announced the national launch of olivia earlier.

Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine, saw its stock soar 35% in mid-day trading on Tuesday ...

With President Donald Trump having returned to power, one of the first things he has done is revoke a 2023 executive order ...